ESMO 2019: Results from the TRAXAR study to assess TRC105 plus axitinib for metastatic kidney cancer

By |2019-09-30T10:55:56+00:0030 Sep 2019|Drug treatments|

Results from the TRAXAR clinical trial to assess TRC105 plus [...]